Form 8-K - Current report:
SEC Accession No. 0001410578-19-000939
Filing Date
2019-08-27
Accepted
2019-08-27 16:27:52
Documents
15
Period of Report
2019-08-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv528250_8k.htm   iXBRL 8-K 26841
2 EXHIBIT 99.1 tv528250_ex99-1.htm EX-99.1 17915
6 GRAPHIC tv528250_ex99-1img01.jpg GRAPHIC 5023
7 GRAPHIC tv528250_ex99-1img02.jpg GRAPHIC 4803
  Complete submission text file 0001410578-19-000939.txt   237501

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gild-20190823.xsd EX-101.SCH 3180
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gild-20190823_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gild-20190823_pre.xml EX-101.PRE 22706
8 EXTRACTED XBRL INSTANCE DOCUMENT tv528250_8k_htm.xml XML 3492
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Filer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19731 | Film No.: 191057660
SIC: 2836 Biological Products, (No Diagnostic Substances)